Are there any clinical studies investigating G6PD inhibitors in cancer?
Research on G6PD inhibitors is still in the preclinical and early clinical stages. Several compounds have shown promise in laboratory settings, demonstrating the ability to inhibit G6PD activity and reduce tumor growth. These studies are crucial for understanding the therapeutic potential and safety profile of G6PD inhibitors. As of now, more research is needed to translate these findings into viable clinical treatments. Researchers are also exploring the combination of G6PD inhibitors with existing cancer therapies to enhance efficacy and overcome resistance mechanisms.
